NDC 63539-025 – Talzenna

Talazoparib Tosylate .5 mg/1 · Capsule, Liquid Filled · Oral

Human Prescription Drug

Product NDC63539-025

Product details

Brand name
Talzenna
Generic name
Talazoparib
Labeler
U.S. Pharmaceuticals
Dosage form
Capsule, Liquid Filled
Route
Oral
Marketing category
NDA · NDA217439
Marketed since
July 9, 2024
Listing expires
December 31, 2027
Pharmacologic class
Poly(ADP-Ribose) Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Talzenna →

Package NDC codes (1)

Package NDCDescriptionSince
63539-025-3030 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-025-30)Jul 9, 2024

Other Talzenna products